2,594
Views
19
CrossRef citations to date
0
Altmetric
Research Articles

Prevention of SARS-CoV-2 cell entry: insight from in silico interaction of drug-like alkaloids with spike glycoprotein, human ACE2, and TMPRSS2

, , , , &
Pages 2121-2145 | Received 15 May 2020, Accepted 07 Oct 2020, Published online: 22 Oct 2020

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Gideon A. Gyebi, Oludare M. Ogunyemi, Adedotun A. Adefolalu, Juan F. López-Pastor, Antonio J. Banegas-Luna, Alejandro Rodríguez-Martínez, Horacio Pérez-Sánchez, Adegbenro P. Adegunloye, Olalekan B. Ogunro, Saheed O. Afolabi, Alaa Baazeem, Saqer S. Alotaibi & Gaber El-Saber Batiha. (2023) Antimalarial phytochemicals as potential inhibitors of SARS-CoV-2 guanine N7-methyltransferase (nsp 14): an integrated computational approach. Journal of Biomolecular Structure and Dynamics 41:11, pages 5022-5044.
Read now
Ahmed Mohamed, Wael Elshemey & Abdo Elfiky. (2022) Can de-phosphorylation of serine-5 in the C-terminal domain of human polymerase II affect its interaction with the PA C-terminal domain of bat Flu A polymerase?. Journal of Biomolecular Structure and Dynamics 0:0, pages 1-10.
Read now

Articles from other publishers (17)

Laraib Ali, Rashid Saif, Muhammad Hassan Raza, Muhammad Osama Zafar, Saeeda Zia, Mehwish Shafiq, Tuba Ahmad & Iram Anjum. (2023) Computational Prediction of Nigella sativa Compounds as Potential Drug Agents for Targeting Spike Protein of SARS-CoV-2. Pakistan BioMedical Journal, pages 18-23.
Crossref
Divine Ainee Celise, James Kimotho, Josephine W. Kimani, Alex Kigundu Muriithi & Eddy Okoth Odari. (2022) Increase in the Immune Response in Balb/c Mice after the Co-Administration of a Vector-Based COVID-19 Vaccine with Cytosine Phosphoguanine Oligodeoxynucleotide. Vaccines 11:1, pages 53.
Crossref
Taku Kinoshita, Masahiro Shinoda, Yasuhiro Nishizaki, Katsuya Shiraki, Yuji Hirai, Yoshiko Kichikawa, Kenji Tsushima, Masaharu Shinkai, Naoyuki Komura, Kazuo Yoshida, Yasutoshi Kido, Hiroshi Kakeya, Naoto Uemura & Junichi Kadota. (2022) A multicenter, double-blind, randomized, parallel-group, placebo-controlled study to evaluate the efficacy and safety of camostat mesilate in patients with COVID-19 (CANDLE study). BMC Medicine 20:1.
Crossref
Chattarin Ruchawapol, Wen-Wei Fu & Hong-Xi Xu. (2022) A review on computational approaches that support the researches on traditional Chinese medicines (TCM) against COVID-19. Phytomedicine 104, pages 154324.
Crossref
Oludare M. Ogunyemi, Gideon A. Gyebi, Afolabi Saheed, Jesse Paul, Victoria Nwaneri-Chidozie, Olufunke Olorundare, Joseph Adebayo, Mamoru Koketsu, Nada Aljarba, Saad Alkahtani, Gaber El-Saber Batiha & Charles O. Olaiya. (2022) Inhibition mechanism of alpha-amylase, a diabetes target, by a steroidal pregnane and pregnane glycosides derived from Gongronema latifolium Benth. Frontiers in Molecular Biosciences 9.
Crossref
Xiao-Huan Liu, Ting Cheng, Bao-Yu Liu, Jia Chi, Ting Shu & Tao Wang. (2022) Structures of the SARS-CoV-2 spike glycoprotein and applications for novel drug development. Frontiers in Pharmacology 13.
Crossref
Shuo Wang, Xuexun Fang & Ye Wang. (2022) In Silico Screening of Novel TMPRSS2 Inhibitors for Treatment of COVID-19. Molecules 27:13, pages 4210.
Crossref
Ahmed Al-Harrasi, Tapan Behl, Tanuj Upadhyay, Sridevi Chigurupati, Shvetank Bhatt, Aayush Sehgal, Saurabh Bhatia, Sukhbir Singh, Neelam Sharma, Shantini Vijayabalan, Vasanth Raj Palanimuthu, Suprava Das, Rajwinder Kaur, Lotfi Aleya & Simona Bungau. (2022) Targeting natural products against SARS-CoV-2. Environmental Science and Pollution Research 29:28, pages 42404-42432.
Crossref
Frage L. Abookleesh, Bader S. Al-Anzi & Aman Ullah. (2022) Potential Antiviral Action of Alkaloids. Molecules 27:3, pages 903.
Crossref
Adriana Ramona Memete, Adrian Vasile Timar, Adrian Nicolae Vuscan, Florina Miere (Groza)Alina Cristiana Venter & Simona Ioana Vicas. (2022) Phytochemical Composition of Different Botanical Parts of Morus Species, Health Benefits and Application in Food Industry. Plants 11:2, pages 152.
Crossref
Mark Tristan J. Quimque, Kin Israel R. Notarte, Von Novi O. de Leon, Joe Anthony H. Manzano, John Emmanuel R. Muñoz, Delfin Yñigo H. PilapilIVIV, Justin Allen K. Lim & Allan Patrick G. Macabeo. 2022. Frontiers of COVID-19. Frontiers of COVID-19 505 537 .
Gideon A. Gyebi, Oludare M. Ogunyemi, Ibrahim M. Ibrahim, Olalekan B. Ogunro, Adegbenro P. Adegunloye & Saheed O. Afolabi. (2021) SARS-CoV-2 host cell entry: an in silico investigation of potential inhibitory roles of terpenoids. Journal of Genetic Engineering and Biotechnology 19:1.
Crossref
Emmanuel Kagning Tsinda & Gideon Sadikiel Mmbando. (2021) Recent updates on the possible reasons for the low incidence and morbidity of COVID-19 cases in Africa. Bulletin of the National Research Centre 45:1.
Crossref
Seyyed Sasan Mousavi, Akbar Karami, Tahereh Movahhed Haghighi, Sefren Geiner Tumilaar, Fatimawali, Rinaldi Idroes, Shafi Mahmud, Ismail Celik, Duygu Ağagündüz, Trina Ekawati Tallei, Talha Bin Emran & Raffaele Capasso. (2021) In Silico Evaluation of Iranian Medicinal Plant Phytoconstituents as Inhibitors against Main Protease and the Receptor-Binding Domain of SARS-CoV-2. Molecules 26:18, pages 5724.
Crossref
C.T. Swamy. (2021) An Overview of COVID-19 and the Potential Plant Harboured Secondary Metabolites against SARS-CoV-2: A Review. Journal of Pure and Applied Microbiology 15:3, pages 1059-1071.
Crossref
Sheng-Teng Huang, Yeh Chen, Wei-Chao Chang, Hsiao-Fan Chen, Hsiang-Chun Lai, Yu-Chun Lin, Wei-Jan Wang, Yu-Chuan Wang, Chia-Shin Yang, Shao-Chun Wang & Mien-Chie Hung. (2021) Scutellaria barbata D. Don Inhibits the Main Proteases (Mpro and TMPRSS2) of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection. Viruses 13:5, pages 826.
Crossref
Isabella Romeo, Francesco Mesiti, Antonio Lupia & Stefano Alcaro. (2021) Current Updates on Naturally Occurring Compounds Recognizing SARS-CoV-2 Druggable Targets. Molecules 26:3, pages 632.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.